# Vico Therapeutics: Research, Leiden, Netherlands

> Vico Therapeutics: Vico Therapeutics is a clinical-stage genetic medicines company based in Leiden, the Netherlands. Based in Leiden, Netherlands. Founded 2019.

Source: https://millionrounds.com/startup/vico-therapeutics (Millionrounds; every figure on the page links to its filing or article)

Netherlands · [Research startup](https://millionrounds.com/companies)

# Vico Therapeutics

Vico Therapeutics is a clinical-stage genetic medicines company based in Leiden, the Netherlands.

Follow Vico Therapeutics and see its new rounds in your feed. [Sign up free](https://millionrounds.com/login?join=1&why=follow&next=%2Fstartup%2Fvico-therapeutics)

Funding reported Last round: Series B

Research Leiden, Netherlands

Company summary

- **Founded:** 2019 7 years old
- **Team:** 49 11 to 50 people
- **Funding reported:** 115.4M as listed, currency not stated
- **Last round:** Series B Jun 2024

How sure we are

- ✓ **Listed** We know it exists and what it does
- 2 **Funding reported** A company dataset reports a raise
- 3 **Observed** A filing or a dated announcement confirms a round

No round for Vico Therapeutics has been confirmed by a filing or an announcement yet, so nothing here counts toward an investor's record. [How we decide](https://millionrounds.com/methodology)

## About Vico Therapeutics

Vico Therapeutics is a clinical-stage genetic medicines company based in Leiden, the Netherlands.

The company specializes in RNA-based science to develop targeted treatments for rare genetic neurological diseases. Vico Therapeutics utilizes a proprietary antisense oligonucleotide (ASO) platform that employs precision chemistry to address the root causes of these disorders while maintaining essential protein function. Recently, the company secured $60 million in Series B financing to advance its lead clinical program and expand its pipeline. The lead product candidate, VO659, is an ASO designed to target the CAG repeat expansion, making it the only ASO in clinical development for all nine known polyglutamine diseases. VO659 is currently in Phase 1/2a clinical development and has received Orphan-Drug Designation from the U.S. FDA for Huntington’s disease and spinocerebellar ataxia. Vico Therapeutics also aims to address conditions such as Rett syndrome and familial Alzheimer’s disease, collaborating with industry consortia to enhance clinical trials for inherited ataxias.

## What company datasets say Vico Therapeutics raised

Funding, as reported

Reported in all **115.4M** in the source's currency

Rounds **3**

Last round **Series B**

Last round size **12.3M**

Last round date **Jun 2024**

Investors listed **11**

## Founders and team

From Vico Therapeutics's own website: 1 founder, 1 on the team.

**Josh Mandel-Brehm** (Co-Founder)

- **Micah Mackison** Chief Executive Officer

## The company, in detail

What they build

Known for

polyglutamine diseases health care rare neurological diseases allele-specific aso biotechnology research allele-preferential targeting cag repeat mutation spinocerebellar ataxias molecular genetics spinocerebellar ataxia treatment neurodegeneration targeted therapy genetic driver targeting hospital & health care antisense oligonucleotide neurodegenerative disease treatment

Built with from their website

Google Tag Manager WordPress.org Google Cloud Elementor Viewport Meta Priority Hints Google Font API imagesLoaded Microsoft Exchange MySQL

+8 more

PrimeNG Microsoft 365 Apps & Services Mobile Friendly Open Graph jQuery Swiper DocuSign TUNE

- **Sector:** Research
- **Industry code:** NAICS 541714, 32541, SIC 2834
- **Region:** South Holland
- **Revenue:** 2M a year, as listed
- **Full record:** [Every detail in the company directory](https://millionrounds.com/directory/vico-therapeutics)

## Research in Netherlands

Startups like it

- [**Citryll** Oss · founded 2015 *Raised*](https://millionrounds.com/company/citryll)
- [**Leyden Labs** Leiden · founded 2020 *Raised*](https://millionrounds.com/company/leyden-labs)
- [**NorthSea Therapeutics** Amsterdam · founded 2017 *Raised*](https://millionrounds.com/company/northsea-therapeutics)
- [**Synerkine Pharma** Leiden · founded 2018 *Raised*](https://millionrounds.com/company/synerkine-pharma)
- [**ENPICOM** 's-Hertogenbosch · founded 2015 *Raised*](https://millionrounds.com/company/enpicom)
- [**PHOSPHOENIX** Amsterdam · founded 2019 *Raised*](https://millionrounds.com/company/phosphoenix)
- [**AZAFAROS B.V.** Naarden · founded 2018](https://millionrounds.com/startup/azafaros-b-v)
- [**VectorY** Amsterdam · founded 2020](https://millionrounds.com/startup/vectory)

## Is this your company?

Add your raise, your deck and your story, and put Vico Therapeutics in front of investors. Or tell us what we have wrong.

[List your startup](https://millionrounds.com/list-your-startup)[Send a correction](https://millionrounds.com/corrections)